The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis
Open accessAbstract
Objectives: This systematic review aimed to describe medication non-adherence among people living with multimorbidity according to the current literature, and synthesise predictors of non-adherence in this population. Methods: A systematic review was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses. PubMed, EMBASE, CINAHL and PsycINFO were searched for relevant articles published in English language between January 2009 and April 2019. Quantitative studies reporting medication non-adherence and/or predictors of non-adherence among people with two or more chronic conditions were included in the review. A meta-analysis was conducted with a subgroup of studies that used an inclusive definition of multimorbidity to recruit participants, rather than seeking people with specific conditions. Remaining studies reporting prevalence and predictors of non-adherence were narratively synthesised. Results: The database search produced 10 998 records and a further 75 were identified through other sources. Following full-text screening, 178 studies were included in the review. The range of reported non-adherence differed by measurement method, at 76.5% for self-report, 69.4% for pharmacy data, and 44.1% for electronic monitoring. A meta-analysis was conducted with eight studies ( n =8949) that used an inclusive definition of multimorbidity to recruit participants. The pooled prevalence of non-adherence was 42.6% (95% CI: 34.0 - 51.3%, k =8, I 2 =97%, p <0.01). The overall range of non-adherence was 7.0%–83.5%. Frequently reported correlates of non-adherence included previous non-adherence and treatment-related beliefs. Conclusions: The review identified a heterogeneous literature in terms of conditions studied, and definitions and measures of non-adherence used. Results suggest that future attempts to improve adherence among people with multimorbidity should determine for which conditions individuals require most support. The variable levels of medication non-adherence highlight the need for more attention to be paid by healthcare providers to the impact of multimorbidity on chronic disease self-management. PROSPERO registration number: CRD42019133849.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
DiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531
The nuts and bolts of PROSPERO: an international prospective register of systematic reviews
Booth, A., Clarke, M., Dooley, G., Ghersi, D., Moher, D., Petticrew, M., & Stewart, L. (2012) · Systematic Reviews · doi:10.1186/2046-4053-1-2 · Cited by 1,433 · cited 2×
“The review was prospectively registered on PROSPERO and a peer-reviewed protocol was published.”
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353
The development of a comorbidity index with physical function as the outcome
GROLL, D., TO, T., BOMBARDIER, C., & WRIGHT, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.018 · Cited by 1,198
Multimorbidity and depression: A systematic review and meta-analysis
Read, J. R., Sharpe, L., Modini, M., & Dear, B. F. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.009 · Cited by 869
Self-report measures of medication adherence behavior: recommendations on optimal use
Stirratt, M. J., Dunbar-Jacob, J., Crane, H. M., Simoni, J. M., Czajkowski, S., Hilliard, M. E., Aikens, J. E., Hunter, C. M., Velligan, D. I., Huntley, K., et al. (2015) · Translational Behavioral Medicine · doi:10.1007/s13142-015-0315-2 · Cited by 824
Research works printed but not linked: 197
- 10.1093/pubmed/fdq057 · DOI
- 10.1001/jama.2012.5265 · DOI · Paper page
- 10.1093/fampra/cmr013 · DOI · Paper page
- 10.1370/afm.4 · DOI · Paper page
- 10.1007/s00228-013-1639-9 · DOI · Paper page
- Zelko, 2016, Medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies, Mater Sociomed, 28, 129, 10.5455/msm.2016.28.129-132 · DOI
- Inauen, 2017, Assessing adherence to multiple medications and in daily life among patients with multimorbidity, Psychol Health, 32, 1233, 10.1080/08870446.2016.1275632 · DOI
- 10.1111/j.1365-2648.2008.04656.x · DOI · Paper page
- 10.1371/journal.pmed.1000097 · DOI · Paper page
- Foley, 2019, Prevalence and predictors of medication non-adherence among patients with multimorbidity: a systematic review protocol, HRB Open Res, 2, 10.12688/hrbopenres.12961.1 · DOI
- Xu, 2017, Mapping the global research landscape and knowledge gaps on multimorbidity: a bibliometric study, J Glob Health, 7, 10.7189/jogh.07.010414 · DOI
- Veritas Health Innovation . Covidence systematic review software. Melbourne, Australia; 2020.
- 10.1016/j.semarthrit.2012.12.001 · DOI · Paper page
- 10.18637/jss.v036.i11 · DOI · Paper page
- 10.1002/sim.1186 · DOI · Paper page
- Gaudiano, 2017, Valued living and its relationship to medication adherence in patients with bipolar and comorbid substance use disorders, J Nerv Ment Dis, 205, 178, 10.1097/NMD.0000000000000533 · DOI
- 10.1097/MJT.0b013e31816b69bc · DOI
- Albrecht, 2017, Adherence and healthcare utilization among older adults with COPD and depression, Respir Med, 129, 53, 10.1016/j.rmed.2017.06.002 · DOI
- Albrecht, 2016, Adherence to maintenance medications among older adults with chronic obstructive pulmonary disease. The role of depression, Ann Am Thorac Soc, 13, 1497, 10.1513/AnnalsATS.201602-136OC · DOI
- 10.1097/MLR.0b013e31829fa8ed · DOI
- 10.1089/apc.2008.0181 · DOI
- 10.1007/s10461-008-9441-x · DOI
- Axon, 2016, Comorbid depression is differentially associated with longitudinal medication nonadherence by race/ethnicity in patients with type 2 diabetes, Medicine, 95, 10.1097/MD.0000000000003983 · DOI
- Baca-Garcia, 2009, Treatment of depressed bipolar patients with alcohol use disorders: plenty of room for improvement, J Affect Disord, 115, 262, 10.1016/j.jad.2008.09.012 · DOI
- Badiee, 2012, Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder, AIDS Patient Care STDS, 26, 388, 10.1089/apc.2011.0447 · DOI
- Baik, 2012, The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure, J Ment Health Policy Econ, 15, 105
- Banegas, 2018, Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer, J Cancer Surviv, 12, 794, 10.1007/s11764-018-0716-6 · DOI
- Batchelder, 2014, Differential medication nonadherence and illness beliefs in co-morbid HIV and type 2 diabetes, J Behav Med, 37, 266, 10.1007/s10865-012-9486-1 · DOI
- 10.1007/s11606-013-2402-8 · DOI
- 10.1097/MLR.0000000000000292 · DOI
- 10.2146/ajhp080238 · DOI
- Berg, 2018, Mental health is a risk factor for poor outcomes in cardiac patients: findings from the National DenHeart survey, J Psychosom Res, 112, 66, 10.1016/j.jpsychores.2018.07.002 · DOI
- Bifftu, 2015, Depression among people with epilepsy in Northwest Ethiopia: a cross-sectional institution based study, BMC Res Notes, 8, 10.1186/s13104-015-1515-z · DOI
- 10.1007/s10461-014-0925-6 · DOI
- Bogner, 2013, Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes, Am J Manag Care, 19, e85
- Cabrera-Marroquín, 2014, Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: the impact on disease outcomes, Clin Exp Rheumatol, 32, 904
- 10.1016/j.ijcard.2016.01.069 · DOI
- 10.1007/s10549-013-2424-2 · DOI
- 10.1002/pds.3660 · DOI
- Calip, 2017, Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors, Breast Cancer Res Treat, 161, 161, 10.1007/s10549-016-4043-1 · DOI
- Cantudo-Cuenca, 2014, Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients, J Manag Care Spec Pharm, 20, 844
- 10.1177/0091217415621267 · DOI
- 10.1002/PDS.3424 · DOI
- 10.1177/0145721712450923 · DOI
- Chou, 2017, Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis, Pharmacoepidemiol Drug Saf, 26, 676, 10.1002/pds.4198 · DOI
- Cicolini, 2016, Self-Reported medication adherence and beliefs among elderly in multi-treatment: a cross-sectional study, Appl Nurs Res, 30, 131, 10.1016/j.apnr.2015.11.011 · DOI
- 10.1016/j.cct.2013.07.010 · DOI
- 10.1007/s11606-014-3072-x · DOI
- 10.1007/s12160-011-9322-9 · DOI
- Cziraky, 2015, Clinical outcomes and medication adherence in acute coronary syndrome patients with and without type 2 diabetes mellitus: a longitudinal analysis 2006-2011, J Manag Care Spec Pharm, 21, 470
- Daniali, 2018, The prevalence of depression and its association with self-management behaviors in chronic disease patients, Iran J Psychiatry, 13
- 10.1177/0956462414535207 · DOI
- Davis, 2011, Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial, Hypertension, 57, 1061, 10.1161/HYPERTENSIONAHA.111.169367 · DOI
- 10.3122/jabfm.2015.06.150010 · DOI
- Desai, 2014, Adherence to oral diabetes medications among users and nonusers of antipsychotic medication, Psychiatr Serv, 65, 215, 10.1176/appi.ps.201300118 · DOI
- Dhamane, 2017, Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients, Int J Chron Obstruct Pulmon Dis, 12, 115, 10.2147/COPD.S114802 · DOI
- Domino, 2014, Heterogeneity in the quality of care for patients with multiple chronic conditions by psychiatric comorbidity, Med Care, 52 Suppl 3, S101, 10.1097/MLR.0000000000000024 · DOI
- DuChane, 2014, Impact of HIV-specialized pharmacies on adherence to medications for comorbid conditions, J Am Pharm Assoc, 54, 493, 10.1331/JAPhA.2014.13165 · DOI
- Eton, 2017, Healthcare provider relational quality is associated with better self-management and less treatment burden in people with multiple chronic conditions, Patient Prefer Adherence, 11, 1635, 10.2147/PPA.S145942 · DOI
- Farley, 2012, Antipsychotic adherence and its correlation to health outcomes for chronic comorbid conditions, Prim Care Companion CNS Disord, 14, m01324
- Ferguson, 2017, Multi-morbidity, frailty and self-care: important considerations in treatment with anticoagulation drugs. outcomes of the AFASTER study, Eur J Cardiovasc Nurs, 16, 113, 10.1177/1474515116642604 · DOI
- Foguet-Boreu, 2017, Pharmacological control of diabetes and hypertension comorbidity in the elderly: A study of "real world" data, Prim Care Diabetes, 11, 348, 10.1016/j.pcd.2017.03.007 · DOI
- Gathright, 2017, The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure, Health Psychol, 36, 839, 10.1037/hea0000529 · DOI
- Gaynes, 2015, Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential, Gen Hosp Psychiatry, 37, 277, 10.1016/j.genhosppsych.2015.03.021 · DOI
- Gentil, 2019, Adherence to oral antihyperglycemic agents among older adults with mental disorders and its effect on health care costs, Quebec, Canada, 2005–2008, Prev Chronic Dis, 12
- Gibson, 2018, Patient expectations of hypertension and diabetes medication: excessive focus on short-term benefits, SAGE Open Med, 6, 1, 10.1177/2050312118821119 · DOI
- Gnanasan, 2011, Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care, Int J Clin Pharm, 33, 44, 10.1007/s11096-010-9452-3 · DOI
- 10.1007/s12160-011-9268-y · DOI
- Grove, 2017, Evaluating the potential for primary care to serve as a mental health home for people with schizophrenia, Gen Hosp Psychiatry, 47, 14, 10.1016/j.genhosppsych.2017.03.002 · DOI
- Gundling, 2013, Clinical manifestations and treatment options in patients with cirrhosis and diabetes mellitus, Digestion, 87, 75, 10.1159/000343458 · DOI
- Gupte-Singh, 2015, Impact of comorbid depression on medication adherence and asthma-related healthcare costs in Texas Medicaid patients with asthma, J Pharm Health Serv Res, 6, 197, 10.1111/jphs.12111 · DOI
- 10.1503/cmaj.131807 · DOI
- 10.1331/JAPhA.2009.08184 · DOI
- Hansen, 2012, Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs, Psychiatr Serv, 63, 920, 10.1176/appi.ps.201100328 · DOI
- 10.1177/1060028014563266 · DOI
- Hansen, 2018, Continuity of medication management among adults with schizophrenia and comorbid cardiometabolic conditions, J Pharm Health Serv Res, 9, 13, 10.1111/jphs.12201 · DOI
- Hapangama, 2013, Substance use disorders among mentally ill patients in a General Hospital in Sri Lanka: prevalence and correlates, Ceylon Med J, 58, 111, 10.4038/cmj.v58i3.6103 · DOI
- Hawke, 2013, Bipolar disorder with comorbid anxiety disorders: impact of comorbidity on treatment outcome in cognitive-behavioral therapy and psychoeducation, Int J Bipolar Disord, 1, 10.1186/2194-7511-1-15 · DOI
- 10.2165/11530680-000000000-00000 · DOI
- Ihle, 2017, Prospective and retrospective memory are differentially related to self-rated omission and commission errors in medication adherence in multimorbidity, Appl Neuropsychol Adult, 24, 505, 10.1080/23279095.2016.1209675 · DOI
- Iyengar, 2016, Medication nonadherence among Medicare beneficiaries with comorbid chronic conditions: influence of pharmacy dispensing channel, J Manag Care Spec Pharm, 22, 550
- James, 2018, Exploratory study of impact of cancer-related posttraumatic stress symptoms on diabetes self-management among cancer survivors, Psychooncology, 27, 648, 10.1002/pon.4568 · DOI
- Jaworski, 2011, Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia, Psychiatry Res, 185, 129, 10.1016/j.psychres.2010.06.005 · DOI
- Jing, 2011, Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members, J Manag Care Pharm, 17, 355
- Joseph, 2017, A study on prescription pattern of antihypertensive agents in chronic renal failure patients and assessment of medication adherence, Int J Pharm Sci Rev Res, 45, 72
- 10.1097/QAI.0b013e3181b720e7 · DOI
- Kalichman, 2015, Medication adherence in people dually treated for HIV infection and mental health conditions: test of the medications beliefs framework, J Behav Med, 38, 632, 10.1007/s10865-015-9633-6 · DOI
- Kamal, 2018, HIV-Infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy, HIV Med, 19, 49, 10.1111/hiv.12542 · DOI
- Katerndahl, 2012, Effect of comorbid depression on outcomes in diabetes and its relationship to quality of care and patient adherence: a statewide primary care ambulatory research and resources consortium study, Prim Care Companion CNS Disord, 14
- 10.1097/PSY.0b013e3181bd8f55 · DOI
- 10.4103/1947-2714.93376 · DOI
- Kenning, 2013, Primary care practitioner and patient understanding of the concepts of multimorbidity and self-management: a qualitative study, SAGE Open Med, 1, 205031211351000, 10.1177/2050312113510001 · DOI
- 10.1097/PSY.0b013e3181c4e3e9 · DOI
- Kong, 2012, Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection, J Gen Intern Med, 27, 1159, 10.1007/s11606-012-2043-3 · DOI
- Kostev, 2018, Association between depression and persistence with oral antihyperglycemic drugs in type 2 diabetes mellitus patients in Germany, Psychiatry Res, 261, 90, 10.1016/j.psychres.2017.12.058 · DOI
- 10.1093/schbul/sbn106 · DOI
- 10.1016/j.psychres.2011.03.013 · DOI
- 10.1192/bjp.bp.114.155820 · DOI
- Krivoy, 2017, Low adherence to antidepressants is associated with increased mortality following stroke: a large nationally representative cohort study, Eur Neuropsychopharmacol, 27, 970, 10.1016/j.euroneuro.2017.08.428 · DOI
- 10.1007/s12160-010-9217-1 · DOI
- Krumme, 2018, Medication synchronization programs improve adherence to cardiovascular medications and health care use, Health Aff, 37, 125, 10.1377/hlthaff.2017.0881 · DOI
- 10.1007/s11126-009-9100-z · DOI
- Langness, 2014, Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy, J Manag Care Spec Pharm, 20, 809
- 10.1007/s10488-010-0320-1 · DOI
- Li, 2016, Medication adherence and blood pressure control among hypertensive patients with coexisting long-term conditions in primary care settings: a cross-sectional analysis, Medicine, 95, 10.1097/MD.0000000000003572 · DOI
- 10.1370/afm.1343 · DOI · Paper page
- Lo Re, 2013, Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients, AIDS Behav, 17, 94, 10.1007/s10461-012-0288-9 · DOI
- 10.2337/dc13-0051 · DOI
- 10.1016/J.JDIACOMP.2017.02.016 · DOI
- 10.1177/1078390310395586 · DOI
- Mathew, 2013, Assessment of medication adherence in type-2 diabetes patients on poly pharmacy and the effect of patient counseling given to them in a Multispecialty Hospital, J Basic Clin Pharm, 5, 15, 10.4103/0976-0105.128251 · DOI
- 10.1016/j.jpsychores.2010.01.026 · DOI
- 10.1177/1090198116637601 · DOI
- 10.1080/09540120802001705 · DOI
- 10.2196/jmir.3269 · DOI · Paper page
- Monroe, 2018, Randomized controlled trial of a pictorial aid intervention for medication adherence among HIV-positive patients with comorbid diabetes or hypertension, AIDS Care, 30, 199, 10.1080/09540121.2017.1360993 · DOI
- 10.1007/s10461-011-0072-2 · DOI
- 10.1080/09540121.2012.672718 · DOI
- 10.1007/s10461-014-0971-0 · DOI
- 10.1053/j.ajkd.2010.02.348 · DOI
- 10.1136/bmjopen-2016-011613 · DOI
- 10.1136/bmjopen-2017-017740 · DOI
- Naidoo, 2013, Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study, BMC Public Health, 13, 10.1186/1471-2458-13-396 · DOI
- Nakimuli-Mpungu, 2019, Recruitment and baseline characteristics of participants in the social, emotional, and economic empowerment through knowledge of group support psychotherapy study (SEEK-GSP): cluster randomized controlled trial, JMIR Res Protoc, 8, 10.2196/11560 · DOI
- Natarajan, 2013, Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension, Can Fam Physician, 59, e93
- Nelson, 2011, Adherence to antihyperlipidemic medication and lipid control in diabetic Veterans Affairs patients with psychotic disorders, Psychosomatics, 52, 310, 10.1016/j.psym.2011.03.004 · DOI
- Nelson, 2011, Medication adherence and glycemic control in patients with psychotic disorders in the Veterans Affairs healthcare system, Pharm Pract, 9, 57
- Neugut, 2016, Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer, JAMA Oncol, 2, 1326, 10.1001/jamaoncol.2016.1291 · DOI
- Newville, 2015, The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance, Int J Behav Med, 22, 214, 10.1007/s12529-014-9429-z · DOI
- 10.1111/j.1524-4733.2008.00474.x · DOI
- Otenyo, 2018, Factors affecting adherence to anti-hypertensive medication regimen among hemodialysis patients attending a private hospital Mombasa, Kenya, Int J Pharm Sci Res, 9, 755
- Owen-Smith, 2016, Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness, Gen Hosp Psychiatry, 38, 9, 10.1016/j.genhosppsych.2015.07.010 · DOI
- Padman, 2017, A study on prescription pattern of oral hypoglycemic agents and insulin therapy in chronic renal failure patients and assessment of medication adherence, Int J Pharm Sci Rev Res, 45, 68
- Pantalone, 2012, Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men, J Behav Med, 35, 520, 10.1007/s10865-011-9381-1 · DOI
- Parpouchi, 2017, Characteristics of adherence to methadone maintenance treatment over a 15-year period among homeless adults experiencing mental illness, Addict Behav Rep, 6, 106
- Patel, 2016, Predictors of medication adherence and persistence in Medicaid enrollees with developmental disabilities and type 2 diabetes, Res Social Adm Pharm, 12, 592, 10.1016/j.sapharm.2015.09.008 · DOI
- Pence, 2015, The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial, AIDS, 29, 1975, 10.1097/QAD.0000000000000797 · DOI
- 10.1345/aph.1L368 · DOI
- Puyat, 2017, Comorbid chronic general health conditions and depression care: a population-based analysis, Psychiatr Serv, 68, 907, 10.1176/appi.ps.201600309 · DOI
- Qian, 2014, Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease, Int J Geriatr Psychiatry, 29, 49, 10.1002/gps.3968 · DOI
- Rattinger, 2012, The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure, Am J Geriatr Pharmacother, 10, 69, 10.1016/j.amjopharm.2011.11.003 · DOI
- Reed, 2018, A self-management support program for older Australians with multiple chronic conditions: a randomised controlled trial, Med J Aust, 208, 69, 10.5694/mja17.00127 · DOI
- Rosenblum, 2014, Efficacy of dual focus mutual aid for persons with mental illness and substance misuse, Drug Alcohol Depend, 135, 78, 10.1016/j.drugalcdep.2013.11.012 · DOI
- Roux, 2012, Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users, Addiction, 107, 152, 10.1111/j.1360-0443.2011.03608.x · DOI
- Saadat, 2015, Adherence to antihypertensives in patients with comorbid condition, Nephrourol Mon, 7, 10.5812/numonthly.29863 · DOI
- 10.1037/a0012715 · DOI · Paper page
- 10.1037/a0028208 · DOI · Paper page
- 10.2337/dc13-0816 · DOI · Paper page
- Santorelli, 2016, Effects of breast cancer on chronic disease medication adherence among older women, Pharmacoepidemiol Drug Saf, 25, 898, 10.1002/pds.3971 · DOI
- 10.1159/000321688 · DOI
- Schüz, 2011, Changes in functional health, changes in medication beliefs, and medication adherence, Health Psychol, 30, 31, 10.1037/a0021881 · DOI
- 10.1016/j.jpsychores.2010.07.014 · DOI
- Schüz, 2014, Multiple illness perceptions in older adults: effects on physical functioning and medication adherence, Psychol Health, 29, 442, 10.1080/08870446.2013.863884 · DOI
- Shi, 2010, Healthcare resource utilization, adherence and persistence with antipsychotic therapy among schizophrenia patients with vs. without pre-existing metabolic syndrome, Curr Med Res Opin, 26, 2499, 10.1185/03007995.2010.519278 · DOI
- 10.1007/s00520-009-0802-4 · DOI
- Shoval, 2017, Low adherence to antidepressants is associated with increased mortality in Parkinson disease patients, Parkinsonism Relat Disord, 43, 92, 10.1016/j.parkreldis.2017.07.032 · DOI
- 10.1371/journal.pone.0053022 · DOI
- Slabbert, 2015, The impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: a prospective study in a South African private healthcare cohort, AIDS Res Ther, 12, 10.1186/s12981-015-0050-2 · DOI
- Soto, 2015, Impact of a pharmacotherapy plan to improve adherence for patients with type-2 diabetes and hypertension in a Chilean Hospital, Int J Clin Pharm, 37, 734, 10.1007/s11096-015-0131-2 · DOI
- 10.1177/1474651409357034 · DOI
- 10.1200/JOP.2014.003046 · DOI
- Taira, 2017, Examining factors associated with nonadherence and identifying providers caring for nonadherent subgroups, J Pharm Health Serv Res, 8, 247, 10.1111/jphs.12193 · DOI
- 10.1177/1054773813481801 · DOI
- 10.1093/arclin/acu092 · DOI
- 10.1016/j.dhjo.2013.02.003 · doi:10.1016/j.dhjo.2013.02.003
- Vatcharavongvan, 2017, Polypharmacy, medication adherence and medication management at home in elderly patients with multiple non-communicable diseases in Thai primary care, Fam Med Prim Care Rev, 19, 412, 10.5114/fmpcr.2017.70818 · DOI
- Vega, 2017, Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder, Curr Med Res Opin, 33, 1879, 10.1080/03007995.2017.1347092 · DOI
- Villar, 2009, Medication adherence and persistence in severe obstructive sleep apnea, Sleep, 32, 623, 10.1093/sleep/32.5.623 · DOI
- 10.1007/s12160-011-9295-8 · DOI
- 10.1089/tmj.2011.0237 · DOI
- 10.1016/j.socscimed.2013.03.012 · DOI
- Wei, 2018, The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: a longitudinal cohort study, Int J Geriatr Psychiatry, 33, e212, 10.1002/gps.4772 · DOI
- Weiss, 2016, Illness perceptions, medication beliefs, and adherence to antiretrovirals and medications for comorbidities in adults with HIV infection and hypertension or chronic kidney disease, J Acquir Immune Defic Syndr, 73, 403, 10.1097/QAI.0000000000001075 · DOI
- Wenze, 2015, Adjunctive psychosocial intervention following hospital discharge for patients with bipolar disorder and comorbid substance use: a pilot randomized controlled trial, Psychiatry Res, 228, 516, 10.1016/j.psychres.2015.06.005 · DOI
- Wong, 2014, The association between multimorbidity and poor adherence with cardiovascular medications, Int J Cardiol, 177, 477, 10.1016/j.ijcard.2014.09.103 · DOI
- 10.1177/0956462414535206 · DOI
- C-H, 2010, The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder, Res Social Adm Pharm, 8, 193
- 10.1345/aph.1P539 · DOI
- 10.1016/j.cardfail.2013.03.010 · DOI
- 10.1007/s10549-018-4890-z · DOI
- Xia, 2015, Impact of mood disorder on medication adherence in patients with chronic diseases at a Shanghai rural hospital, Int J Pharmacol, 11, 518, 10.3923/ijp.2015.518.522 · DOI
- Xue, 2019, Treatment adherence as a mediator of blood pressure control in Chinese older adults with depression, Int J Geriatr Psychiatry, 34, 432, 10.1002/gps.5032 · DOI
- Yang, 2010, Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs, J Am Pharm Assoc, 50, 527, 10.1331/JAPhA.2010.09071 · DOI
- 10.1016/0021-9681(87)90171-8 · DOI · Paper page
- 10.1080/08870446.2012.662973 · DOI
- 10.1016/j.ijnurstu.2014.10.010 · DOI · Paper page
- Pednekar, 2019, Methods for measuring multiple medication adherence: a systematic Review-Report of the ISPOR medication adherence and persistence special interest group, Value Health, 22, 139, 10.1016/j.jval.2018.08.006 · DOI
- 10.1176/appi.ps.58.2.207 · doi:10.1176/appi.ps.58.2.207
- 10.4088/JCP.8001tx17c · DOI
- 10.1186/s12877-019-1031-4 · DOI
- Dezii, 2002, Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes, South Med J, 95, 68, 10.1097/00007611-200295010-00014 · DOI
- 10.1038/s41598-018-23276-8 · DOI · Paper page
- Khan, 2018, Challenges and innovations of drug delivery in older age, Adv Drug Deliv Rev, 135, 3, 10.1016/j.addr.2018.09.003 · DOI
- 10.1007/s40266-014-0153-9 · DOI
- 10.1016/j.cger.2012.01.008 · DOI · Paper page
- Lam, 2015, Medication adherence measures: an overview, Biomed Res Int, 2015, 1
- 10.2165/00002512-200421120-00004 · DOI · Paper page
Cited by
2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C., Andreotti, F., Koskinas, K. C., Rossello, X., Adamo, M., Ainslie, J., Banning, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 2,774
Medication Adherence and Functioning in Individuals With Bipolar Disorder Type I.
Yilmaz, E. B., Dikmen, S. N. T., & Yüksel, A. (2025) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20240930-01 · Cited by 1
Metadata
- Authors
- Foley, L., Larkin, J., Lombard-Vance, R., Murphy, A. W., Hynes, L., Galvin, E., & Molloy, G. J.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2021-09
- Volume
- 11
- Issue
- 9
- Pages
- e044987
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W3197047107
- Cited by
- 208
- References
- 16
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-07-18)
- Open access
- gold
- Funders
- Health Research Board (CDA-2018-003)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1136/bmjopen-2020-044987
- The paper
- Foley, L., Larkin, J., Lombard-Vance, R., Murphy, A. W., Hynes, L., Galvin, E., & Molloy, G. J. (2021). Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2020-044987
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.